Lemax Technology (02539): Hong Kong public offering was oversubscribed 7324.29 times. The issue price is HK$40 per share.
Lemon Tech (02539) announces the results of its distribution, with a total of 5.5556 million H shares being offered globally. The public offering in Hong Kong accounts for 10%, while the international offering accounts for 90%. The offering price per share is 40 Hong Kong dollars, with a net capital raise of approximately 182 million Hong Kong dollars globally. Trading of H shares is expected to begin on Wednesday, December 3, 2025, at 9:00 am on the Hong Kong Stock Exchange.
LemTech (02539) announced the results of its distribution, with a total of 5.5556 million H shares sold globally. The public sale in Hong Kong accounted for 10%, while the international sale accounted for 90%. The selling price per share was HK$40, with a total net proceeds of approximately HK$182 million from the global sale. Trading of H shares is expected to begin on December 3, 2025 (Wednesday) at 9:00 am on the Hong Kong Stock Exchange.
The public sale in Hong Kong received 7324.29 times oversubscription, while the international sale received 6.78 times oversubscription.
Related Articles
MICROTECH MED-B(02235) spent HK$210,100 on December 2nd to repurchase 31,700 shares.
Shanghai Fosun Pharmaceutical (02196): The drug registration application for Sodium Chloride Injection has been accepted by the National Medical Products Administration.
Fujian Acetron New Materials (300706.SZ) plans to raise funds through private placement of not more than 900 million yuan.
MICROTECH MED-B(02235) spent HK$210,100 on December 2nd to repurchase 31,700 shares.
Shanghai Fosun Pharmaceutical (02196): The drug registration application for Sodium Chloride Injection has been accepted by the National Medical Products Administration.
Fujian Acetron New Materials (300706.SZ) plans to raise funds through private placement of not more than 900 million yuan.
